Cardiovascular effects of single oral doses of the new beta- adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
- 1 June 1980
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 9 (6), 569-575
- https://doi.org/10.1111/j.1365-2125.1980.tb01082.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cycloporpylmethoxytheyl)-1-phenoxy-3-isopropyl- aminograpan-2-ol], a new β1 adrenoceptor blocking agentJournal of Chromatography A, 1979
- Pharmacokinetics, pharmacology of atenolol and effect of renal disease.British Journal of Clinical Pharmacology, 1979
- Onset and duration of beta-adrenergic receptor blockade following single oral dose acebutolol hydrochloride (Sectral).British Journal of Clinical Pharmacology, 1979
- Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.British Journal of Clinical Pharmacology, 1979
- Clinical Pharmacokinetics of PropranololClinical Pharmacokinetics, 1979
- Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertensionCurrent Medical Research and Opinion, 1978
- Absorption of the β-Adrenergic-Blocking Agent, Nadolol, by Mice, Rats, Hamsters, Rabbits, Dogs, Monkeys, and Man: An Unusual Species DifferenceXenobiotica, 1978
- Combined pharmacokinetic and pharmacodynamic studies in man of the adrenergic β1‐receptor antagonist metoprolol *Acta Pharmacologica et Toxicologica, 1975
- THE ASSESSMENT OF β‐ADRENOCEPTOR BLOCKING DRUGS IN HYPERTHYROIDISMBritish Journal of Clinical Pharmacology, 1974
- Pharmacokinetic Properties of the ??-Adrenergic Receptor Blocking DrugsDrugs, 1974